With help of a blood biomarker, doctors may very soon be able to detect lung cancer early in its stage.
A new study has shown that patients with stage I to stage III non-small cell lung cancer have different metabolite profiles in their blood than those of patients who are at risk but do not have lung cancer.
Researchers at Cleveland Clinic studied the blood serum of 284 subjects, 48 percent of whom were female with a mean age of 68 years. The subjects were diagnosed with adenocarcinoma ...
With help of a blood biomarker, doctors may very soon be able to detect lung cancer early in its stage.
A new study has shown that patients with stage I to stage III non-small cell lung cancer have different metabolite profiles in their blood than those of patients who are at risk but do not have lung cancer.
Researchers at Cleveland Clinic studied the blood serum of 284 subjects, 48 percent of whom were female with a mean age of 68 years. The subjects were diagnosed with adenocarcinoma ...